socalTechnews
Home
Mobile
News and Events
  • Headlines
  • Events
  • Interviews
  • Jobs
  • Directory
    		•
    Members Only
  • Networking
  • Venture Deals
  • Venture Firms
  • Companies
    • About
  • Membership
  • About
  • Contact Us
    		•
    Search News
    Monday, May 22, 2006

    Naryx Pharma Gets $8M
    Santa Barbara-based Naryx Pharma has received $8M in venture funding, saying this morning that it has raised a Series B2 round from Vivo Ventures and Sutter Hill Ventures. Naryx is developing proprietary products for the treatment of chronic sinusitis. The firm is heade dby Robin Campbell, former General Manager and Vice President of the Oncology Business Unit at Amgen. Chen Yu and Ed Engleman of Vivo will join the company's board of directors.
    posted on Monday, May 22, 2006 (Link to more information)

    Related companies:
    Naryx Pharma

    Related stories:
    > IDM Pharma Gets $12.8 in PIPE
    > Allergan Buys Esprit Pharma
    > Domain Adds Evoke Pharma To Portfolio
    > Meritage Pharma Gets $22.5M
    > aTyr Pharma Raises $10.5M

    RSS Feed
    subscri be via emailNewsletter


    Previous news:

     Thursday, August 21, 2008
    Wednesday, August 20, 2008
    Tuesday, August 19, 2008
    Monday, August 18, 2008
    Friday, August 15, 2008